This federal contract award is for the delivery of Ultomiris, a pharmaceutical product, to the Defense Logistics Agency (DLA). The fixed-price contract, valued at $48,444.54, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 7, 2024 and was awarded on October 17, 2024. The contract is a delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger indefinite delivery contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 1/16/25, 9:29 AM